Oncopeptides AB
OTC:ONPPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oncopeptides AB
OTC:ONPPF
|
SE |
|
Corestate Capital Holding SA
F:CCAP
|
LU |
|
A
|
Acciona SA
DUS:AJ3
|
ES |
|
S
|
Synthomer PLC
F:7YC
|
UK |
|
H
|
Houghton Mifflin Harcourt Co
F:HM0
|
US |
|
B
|
Biofrontera AG
XMUN:B8F
|
DE |
|
C
|
Calima Energy Ltd
F:R1Y
|
AU |
|
P
|
Purifloh Ltd
F:WXV
|
AU |
|
A
|
Acciona SA
XMUN:AJ3
|
ES |
Wall St Price Targets
ONPPF Price Targets Summary
Oncopeptides AB
According to Wall Street analysts, the average 1-year price target for ONPPF is 0.352 USD with a low forecast of 0.282 USD and a high forecast of 0.455 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ONPPF's stock price target?
Price Target
0.352
USD
According to Wall Street analysts, the average 1-year price target for ONPPF is 0.352 USD with a low forecast of 0.282 USD and a high forecast of 0.455 USD.
What is the Revenue forecast for Oncopeptides AB?
Projected CAGR
73%
The compound annual growth rate for Revenue over the next 3 years is 73%.
What is the Gross Profit forecast for Oncopeptides AB?
Projected CAGR
102%
The compound annual growth rate for Gross Profit over the next 2 years is 102%.
